EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patents RE44846 and RE44847. These patents are reissued versions of U.S. Patents 7,744,582, and 7,776,015. Tracing back to inventions made in the late 1990’s, the patents capture innovations in the field of auto injectors that originally established Antares Pharma’s position as a leader and innovator in medical injection device technology. Importantly, these patents add protection to OTREXUP as well as Antares’ pipeline products. Antares is taking steps to supplement the current Orange Book listings related to OTREXUP.
Help employers find you! Check out all the jobs and post your resume.
